This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascularintervention and accelerates its shift into higher-growth markets. Cardiovascularintervention is one of the fastest-growing global medtech markets, with significant unmet patient need.
(Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrialfibrillation (AFib) to breast cancer was piloted by scientists. American College of Cardiology Journal) Are you thinking of stopping your antiplatelet medication too soon after angioplasty? Reconsider your position.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
AFIB 
105 
Let's personalize your content